A new study published in the New England Journal of Medicine calls for urgent action and a complete overhaul of chemical laws and...

Lorna Rothery interviewed Dr John Glod from the National Cancer Institute, which is part of the National Institutes of Health, about the...

Obesity at cancer diagnosis appeared linked to significantly poorer survival among children and adolescents, according to results of a...

Survivors of childhood cancer face challenges from bone mineral density (BMD) deficits due to treatment exposures and other factors, some...

Indoximod works to reverse the mechanisms that cancer tumors use to hide from the immune system . The chemotherapy damages the tumor,...

Adolescent and young adult (AYA) patients with cancer, who find themselves between pediatric and adult patients, often face concerns and...

New research from Dana-Farber Cancer Institute has found that rare germline genetic abnormalities could increase the risk of childhood...

“Patient response to revumenib has been good in other clinical trials,” explains Cuglievan. “But it’s also been short-lived when used...

There’s new evidence that Larotrectinib (Vitrakvi), by Loxo Oncology and Bayer, is highly effective in children with newly diagnosed...

The survival rate for children with a rare but deadly cancer could one day be improved by adding an existing drug—which is currently used...